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Objective: Proximal neck dilatation (PND) and/or endograft migration with the subsequent development of type I
endoleak is a significant cause of late endograft failure after endovascular abdominal aortic aneurysm repair (EVAR).
Although there are numerous reports examining PND in patients receiving endografts that use self-expanding stents
(SES) for proximal fixation, there are no such reports for patients treated with endografts that use balloon-expanding
stents (BES). The purpose of this study was to investigate PND and endograft migration after EVAR with BES
endografts.
Methods: We retrospectively reviewed all charts and all serial computed tomographic scans available for patients who
underwent EVAR with a BES endograft (surgeon-made, aortounifemoral polytetrafluoroethylene graft with a proximal
Palmaz stent) between August 1997 and October 2002. Only patients with longer than a 12-month follow-up were
analyzed. Neck diameter was measured at the level of the lowest renal artery and at 5 mm below it. PND was defined as
neck enlargement of 2.5 mm or more. To assess endograft migration, the distance between the superior mesenteric artery
and the cranial end of the BES was measured. Stent migration was defined as a change of 5 mm or more.
Results: A total of 77 patients received this device during the study period. The technical success rate was 99%. The 1-, 3-,
and 5-year survival was 66%, 48%, and 29.5%, respectively. Complete serial computed tomographic scans were available
in 41 of the 48 patients who survived 12 months or longer after the operation. The mean follow-up period for these
patients was 31 months (range, 12-66 months). The maximum aneurysm diameter was either unchanged or decreased in
35 patients (85%). The immediate postoperative proximal neck diameter was 19 to 29 mm (median, 24 mm). This was
unchanged at the latest follow-up. None of the patients had significant PND. The cranial end of the BES was located in
the area between 14 mm proximal and 36 mm distal to the superior mesenteric artery (median, 6 mm). None of the
patients developed significant endograft migration.
Conclusions:Neither PND nor endograft migration was observed with the BES endograft. The nature of the SES may be
responsible for the observed neck dilatation and device migration after EVAR with SES endografts. This study suggests
that BES may be a better fixation method for EVAR. (J Vasc Surg 2005;42:639-44.)Endovascular abdominal aortic aneurysm repair (EVAR)
has gained popularity over the last decade. It has proven to
be effective in preventing rupture.1-3 The initial reports
showed operative mortality similar to that with open re-
pair.4-6 However, more recent prospective randomized
data from the EVAR 1 and Dutch Randomized Endovas-
cular Aneurysm Management “DREAM” trials showed
significant reductions in operative mortality in favor of the
endovascular repair.7 The reduction in morbidity is remark-
ably pronounced with EVAR.1,2,8-10 Since its introduction
in the early 1990s by Parodi et al,11 EVAR has undergone
significant refinement in devices and operative techniques.
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tion rate, most of which is secondary to endoleak and graft
migration resulting in sac expansion.12-14 Postoperative
neck enlargement has been reported in 10% to 36% of
cases.15-23 Loss of proximal fixation will result in graft
instability and possible migration and endoleak. There are
two different types of endovascular grafts: self expandable
and balloon expandable. The former is more common. All
previous studies have reviewed proximal neck dilatation
(PND) and graft migration after EVAR with self-expanding
stent (SES) endografts. This study evaluates PND and graft
migration after EVAR with balloon-expanding stent (BES)
endografts.
METHODS
Device. The Montefiore Endografting System (MEGS)
has been described elsewhere.24-26 In brief, the MEGS
consists of an aortounifemoral polytetrafluoroethylene
graft (IMPRA, Tempe, Ariz) sutured to a proximal BES
(Palmaz 5014, 4014; Cordis, Warren, NJ). The proximal
end of the graft is predilated with a large balloon to 30 mm
in diameter. The stent-graft combination is mounted onto
a large angioplasty balloon (Maxi LD; 25 mm  4 cm;
639
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16F sheath (Cook Inc, Bloomington, Ind). The MEGS was
used under an investigator-sponsored investigational de-
vice exemption approved by the Food and Drug Adminis-
tration. Institutional review board approval was also ob-
tained. MEGS were used for patients who were not
candidates for either open surgery or industry-made en-
dografts. The main reason for exclusion from industry-
made endografts was unfavorable proximal neck anatomy,
including a highly angulated (60°) and/or short (15
mm) neck. In addition, MEGS was preferentially used for
ruptured abdominal aortic aneurysms.24-26
Techniques. The graft was deployed just below the
level of the lowest renal artery. The proximal stent was
deployed in the suprarenal area. By varying the inflation
pressure of the balloon, the device was able to accommo-
date a wide range of aortic neck diameters (from 20 to 28
mm). Because the length of the graft was 40 cm, the distal
end of the graft always protruded through the ipsilateral
femoral arteriotomy and could be cut to accommodate the
appropriate length for each patient. An endoluminal hand-
sewn anastomosis was performed to the inside of the distal
external iliac or the common femoral arteries. Either a
Smart stent (Cordis, Warren, NJ) or a Wall stent (Boston
Scientific, Natick, Mass) was deployed in the iliac portion.
An occluder device was placed in the contralateral common
iliac artery to prevent retrograde perfusion of the aneurysm.
A femorofemoral polytetrafluoroethylene bypass was then
performed.
Follow-up. Computed tomographic (CT) scans were
obtained with intravenous contrast medium. Scans were
obtained from 1 cm above the celiac artery down to the
femoral arteries. A collimation of 3 mm and a pitch of 2 mm
were used to cover the entire anatomic region. Images were
reconstructed at 1.5-mm intervals, according to our insti-
tutional protocol. No oral contrast medium was used. CT
scans were obtained before surgery (except in rupture
cases); at 1, 6, and 12 months after surgery; and yearly
thereafter. All CT scans were reviewed independently by
two vascular surgeons. Comparison was made between the
immediate postoperative and latest follow-up scans. Be-
cause the purpose of the study was to evaluate the long-
term outcome of the MEGS, patients who died within 12
months from the date of the operation were excluded from
the analysis.
Measurements. The proximal aortic neck was mea-
sured as the outer diameter in the minor axis at two
different levels: at the level of the lowest renal artery and 5
mm distal to the first level. Care was taken to consider the
tortuosity of the proximal aorta to avoid overestimation of
the neck dimension. We defined aortic neck dilatation as an
increase in the diameter of 2.5 mm or more. For device
migration, the distance from the level of the superior mes-
enteric artery (SMA) to the CT cut that contained at least
one half of the proximal Palmaz stent was measured. We
defined graft migration as stent movement of 5 mm or
more.RESULTS
During the study period, 77 patients with abdominal
aortic aneurysm underwent a repair with the MEGS. There
were 20 women and 57 men. Patient ages ranged between
62 and 92 years (mean, 77 years). Most of the patients had
severe comorbidities: 52% had coronary artery disease, 44%
had chronic obstructive pulmonary disease, 18% had chronic
renal disease, 65% had hypertension, 81% had a long-term
history of heavy tobacco smoking, and 8% had diabetes
mellitus. Indications24-26 for using the MEGS instead of
the commercially available SES graft were neck angulation
greater than 60° (22%), neck diameter greater than 26 mm
(10%), neck length less than 15 mm (17%), bilateral iliac
involvement (11%), small and or tortuous iliac arteries
(32%), and ruptured aneurysm (8%).
The technical success rate was 99%. One patient re-
quired conversion to an open procedure, and seven patients
(9%) developed endoleak. Type II endoleak occurred in six
patients, but none required intervention. Type I endoleak
occurred in one patient (1.2%) and necessitated reopera-
tion with deployment of an additional Palmaz stent at the
proximal neck. A thrombosed femorofemoral bypass graft
necessitating thrombectomy occurred in one patient
(1.2%) secondary to transection caused by an incision made
Fig 1. Kaplan-Meier analysis for one-year, three-year and five-
year survival was 66%, 48%, and 29.5%, respectively.for colostomy closure. Graft occlusion developed in six
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the remaining four were treated with axillary-bifemoral
bypasses. One patient required reoperation for hemorrhage
from femorofemoral suture dehiscence. One patient devel-
oped a kink in the middle of the graft which was repaired
with deployment of a metallic stent. Although no graft
infection occurred, two patients (2.5%) had wound infec-
tions.
Kaplan-Meier analysis showed the 1-, 3-, and 5-year
survival to be 66%, 48%, and 29.5%, respectively (Fig 1).
Twenty-four patients (31%) died from cardiopulmonary
complications, four patients (5%) died from cancer, and
one patient (1%) died secondary to aneurysm rupture.
Seven patients (9%) were lost to follow-up. Complete serial
CT scans were available in 41 of the 48 patients who
survived 12 months or longer after the operation. The
Fig 2. The immediate post-op proximal neck diameter ranging
between 19 and 29 mm (median24 mm), remained unchanged
at the latest follow-up. Post OP, After surgery; F/U, follow-up.
Fig 3. Most of the patients had no change in the PND at the
latest follow up. Few patients had 1 mm change and only two
patients had an increase of 2 mm in PND.mean follow-up period for these patients was 31 months(median, 28 months; range, 12-66 months). More than
60% of patients had longer than 24 months of follow-up,
whereas 39% of patients had longer than 36 months of
follow-up. The maximum aneurysm diameter was un-
changed in 17 patients (41%). In 18 patients (44%), the
aneurysm decreased in size. Six patients (15%) had endo-
tension with a significant increase in aneurysm diameter
(median, 9.5 mm; range, 5-22 mm), despite the absence of
an endoleak. The preoperative mean neck diameter was
23.1 mm (median, 23 mm; range, 18-28 mm). The device
was oversized by approximately 5%, making the mean in-
traoperative PND 1 mm (range, 0.5-2 mm). The immedi-
ate postoperative mean proximal neck diameter was 24 mm
(median, 24 mm; range, 19-29 mm; Fig 2). This remained
unchanged at the latest follow-up (mean, 24 mm; median,
24 mm; range, 19-29 mm). Twenty-six patients (63%) had
the same measurement of the proximal neck (Fig 3). Eight
patients (20%) had a decrease of 1 mm and five patients
(12%) had an increase of 1 mm in the proximal neck
diameter. Two patients (5%) had an increase of 2 mm.
None had significant PND (2.5 mm). The top of the BES
(Fig 4) was located in the area between 14 mm proximal
Fig 4. The location of the balloon-expanding stent (BES) re-
mained stable at the latest follow-up. The top of the BES was
located in the area between 14 mm proximal and 36 mm distal to
the superior mesenteric artery (median, 6 mm). Post op, After
surgery; SMA, superior mesenteric artery; F/U, follow-up.
Fig 5. While only three patients had a graft movement of 2-3
mm, none of the patients had true migration of 5 mm or greater.and 36 mm distal to the SMA (median, 6 mm). This was
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completely stable (Fig 5) in 38 patients (93%). In two
patients (5%), the graft migrated 2 mm. Only one patient
(2%) had a 3-mm migration. None had greater than a
3-mm migration.
DISCUSSION
The long-term durability of the endovascular repair of
abdominal aortic aneurysms is highly dependent on the
integrity of the proximal fixation site. It is known that the
infrarenal aortic cuff tends to dilate even after conventional
aneurysm repair. This can occur an average of 0.5 mm per
year after surgery.27 The effect of this dilatation is more
significant after endovascular repair, because such dilata-
tion may result in the loss of proximal fixation and, possibly,
graft migration or endoleak. An increase of 5 mm is con-
sidered significant (10% of an average aneurysm size). This
is in accordance with the Society of Vascular Surgery re-
Table. Incidence of PND and graft migration after EVAR
Study Device No. pati
Wever15 Ancure* 33
Makaroun16 Ancure 314
Conners17 AneuRx† 81
Sternbergh18 Zenith‡ 351
Zarins19 AneuRx 1119
Badran20 Vanguard§
AneuRx
Zenith
Talent
Stentor
Others
73
Cao21 AneuRx
Excluder
Zenith
Talent¶
230
Resch22 Ivancev-Malmo (aortouni-iliac) 65
Napoli23 AneuRx
Excluder
Zenith
Endologix#
Talent
Others
90
*Endovascular Technologies EVT, Guidant (Menlo Park, Calif).
†Medtronics/AVE Inc (Sunnyvale, Calif).
‡Cook Inc (Bloomington, Ind).
§Min Tech (Freeport, Bahamas).
¶W.L. Gore and Associates (Flagstaff, Ariz).
World Medical/Medtronics (Sunrise, Fla).
#Endologix (Irvine, Calif).porting standards for EVAR.28 We used 2.5 mm as a cutofffor significant PND (10% of the average aortic neck diam-
eter). The reporting standards define graft migration as
graft movement of 10 mm or more relative to an anatomic
landmark. We considered any migration greater than 5 mm
to be significant. Most prior studies have used the lowest
renal artery as a landmark to monitor graft migration. The
reason for use of the SMA as a landmark for migration in
this study was that all of our patients had suprarenal fixation
with the Palmaz stent. Even with more strict standards, our
data demonstrate an impressive 0% dilatation/migration
rate. Most grafts available today for EVAR are SES en-
dografts. The short-, mid-, and long-term PND and graft
migration after EVAR with these grafts have been studied
extensively and are summarized in the Table.15-23 Because
the SES endograft is oversized by 10% to 20% of the
preoperative proximal neck diameter at the time of EVAR,
it retains its expansive radial force. BES is oversized by 5%.
The Palmaz stent will maintain its diameter after the initial
SES grafts
PND Migration
10.3% at 6 mo
15.5% at 12 mo
13% at 1 y
21% at 2 y
19% at 3 y
All patients with migration
had significant PND
7.2% at 1 y
20.4% at 2 y
42.1% at 3 y
66.7% at 4 y
15% at 1 y
(30% graft oversizing)
27% at 1 y
(30% graft oversizing)
0.9% at 1 y
(30% graft oversizing)
14% at 1 y
(30% graft oversizing)
2.1% at 1 y
7.2% at 2 y
18.8% at 3 y
33% at 2 y
28% at 2 y
22% at 3 y 45% at 3 y
13% at 1 y
33% at 2 y
36% at 3 y
10.8% at 1 y
18% at 2 y
18.1% at 3 ywith
entsdeployment dilatation and does not exert any ongoing
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two opposite forces: the recoil force of the elastic aortic wall
and the expansive radial force of the proximal endograft
stent. If the radial force were greater than the recoil force, as
seen with the 20% oversized SES, PND would be imminent. If
the recoil force were greater than the radial force, PND would
be less likely. This may be partially responsible for the 0% PND
in BES in comparison with the observed 10% to 36% PND in
SES.15-23 The documented 1- to 2-mm PND (17% of our
patients) is well within the interobserver measurement vari-
ability interval.29 The natural tendency for the infrarenal
aorta to dilate (0.5 mm per year)27 and the 5% intraoperative
oversizing of the BES could be additional factors contributing
to the minimal neck dilatation observed in our patients.
There is a clear association between PND and migra-
tion.17,22,23 SES endografts migrate at a 10% to 40%
rate.17-19,22,23 Resch et al22 documented that 50% of pa-
tients with migration had significant PND. Napoli et al23
showed that 35% of the patients with significant PND had
graft migration.
In contrast to studies with SES, we did not observe
endograft migration. Several reasons may explain these
differences. The absence of PND with BES-based endografts
is an important factor in preventing migration.22,23
Suprarenal fixation is another important factor that
might decrease the incidence of migration. Although some
authors have shown no significant relation between migra-
tion and the type and model of the prosthesis (suprarenal vs
infrarenal fixation),23 others have documented a low inci-
dence of migration (14%) in SES endografts with suprare-
nal fixation.18 This incidence is significantly lower than the
alarming 40% to 60% migration rates that are docu-
mented with some of the infrarenal fixation SES grafts.17
Suprarenal fixation would decrease migration but would
not eliminate it.
The Palmaz stainless-steel stent has minimal recoil and
acts as a cylinder against which the elastic aortic wall exerts
force. This results in an impressive strength that stabilizes
the aortic neck. Resch et al,30 with a cadaveric model,
studied the force required to dislodge a variety of endografts.
The Palmaz-based balloon-expandable endograft required
more dislodgement force than the Ancure (Endovascular
Technologies EVT, Guidant, Menlo Park, Calif), Talent
(World Medical/Medtronics, Sunrise, Fla), Vanguard
(Min Tech, Freeport, Bahamas), and Zenith (Cook Inc,
Bloomington, Ind) endografts, all of which use the SES.
This secure fixation may explain the absence of stent
migration. In addition, tissue incorporation is minimal
with SES endografts. In 2 studies, 29 devices were ex-
planted either at late conversion or at autopsy up to 3 years
after implantation.31,32 All specimens were studied with the
highest standards—anatomic, histologic, and biochemical
methods of investigation. No evidence of even traces of
incorporation of the grafts by the native tissue was found in
any of the cases.33 The lack of tissue incorporation will lead
to proximal stent migration in the presence of PND. Con-
versely, the BES graft with the Palmaz stent strut, well
embedded into the aortic wall and actually breaking theinternal elastic lamina, stimulates significant inflammation,
smooth muscle proliferation, and intimal hyperplasia.34
This results in aggressive incorporation of the struts within
the fibrous tissues.35 This inflammatory response and tissue
incorporation of the BES may have added stability to the
graft and prevented future migration.
During EVAR, we have observed micromotion of the
SES with fluoroscopy. The SES grafts pulsate with every
heartbeat. This repetitive micromotion, which is not ob-
served with the BES, causes a continuous strain on the stent
and may be responsible for stent fatigue fractures and PND.
For example, Zarins et al36 studied these structural defects
on more than 100 explanted SES grafts. Stent fractures
occurred in 66% of the explants. This study showed more
stent strut fractures in grafts that showed migration before
explantation.
One other factor that may explain the absence of PND
and migration in BES grafts is the precision of deployment.
This allows maximal coverage of the neck, which could be
an inhibitory factor of PND. A few millimeters of uncov-
ered neck left above the SES graft will be prone to future
dilatation. Zarins et al19 showed a clear and direct correla-
tion between graft migration and the distance between the
lowest renal artery and top of the stent graft. Each millime-
ter increase between the renal arteries and the proximal
graft fixation site increases the risk for subsequent migra-
tion by 5.8%, and each millimeter increase in proximal
fixation length decreases the risk of migration by 2.5%.
The Lifepath (Edwards Lifesciences Corporation, Ir-
vine, CA) system is another BES device. The device is no
longer available; however, the data are very useful in this
discussion. In comparison with the MEGS grafts, this de-
vice lacks a suprarenal stent. It uses a stented endoskeleton
constructed from Elgiloy. The migration rate was 0% for
the second-generation devices.37 This emphasizes that su-
prarenal fixation is not the only factor in reducing migra-
tion incidence. Both the Lifepath and the MEGS devices
are BES, eliminate ongoing radial stress to the aortic neck,
and allow more precise deployment, thus resulting in less
PND and migration. The importance of PND and graft
migration is emphasized in the recent finding that late
rupture after EVAR is related to graft migration rather than
aneurysm dilatation.7
The limitation of this study is the small sample size.
This was a group of patients with severe comorbidities and
highly complex aneurysms. These patients had a high non–
aneurysm-related mortality rate, which further decreased
the length of follow-up. However, most of the available
data on SES grafts showed a significant PND and migration
rate at 1- to 3-year follow-up (Table).15-23 More than 60%
of our patients had more than 24 months of follow-up,
whereas 39% of patients had more than 36 months of
follow-up.
CONCLUSIONS
Although the sample size is small, this study shows that
neither PND nor migration occurs after BES endografting.
This observation suggests that BES may be a better plat-
JOURNAL OF VASCULAR SURGERY
October 2005644 Malas et alform for endograft fixation, which is the cornerstone for a
durable EVAR.
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